Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹852 Cr₹1,097 Cr₹747 Cr₹768 Cr₹704 Cr

What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS is ₹852 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹852 Cr
Mar2024₹1,097 Cr
Mar2023₹747 Cr
Mar2022₹768 Cr
Mar2021₹704 Cr

How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹852 Cr
-22.38
Mar2024 ₹1,097 Cr
46.92
Mar2023 ₹747 Cr
-2.78
Mar2022 ₹768 Cr
9.05
Mar2021 ₹704 Cr -

Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,487.5 Cr -2.6% 5.9% 44.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹97,115.7 Cr -1.7% -8.4% -16.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.6%

5.9%

44.7%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses